Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Summary

Liver injuries are accompanied by progenitor cell expansion that represents a heterogeneous cell population. Novel classification of this cellular compartment allows for the distinguishing of multiple subsets. The method described here illustrates the flow cytometry analysis and high purity isolation of various subsets that can be used for further assays.

Abstract

During chronic liver injuries, progenitor cells expand in a process called ductular reaction, which also entails the appearance of inflammatory cellular infiltrate and epithelial cell activation. The progenitor cell population during such inflammatory reactions has mostly been investigated using single surface markers, either by histological analysis or by flow cytometry-based techniques. However, novel surface markers identified various functionally distinct subsets within the liver progenitor/stem cell compartment. The method presented here describes the isolation and detailed flow cytometry analysis of progenitor subsets using novel surface marker combinations. Moreover, it demonstrates how the various progenitor cell subsets can be isolated with high purity using automated magnetic and FACS sorting-based methods. Importantly, novel and simplified enzymatic dissociation of the liver allows for the isolation of these rare cell populations with a high viability that is superior in comparison to other existing methods. This is especially relevant for further studying progenitor cells in vitro or for isolating high-quality RNA to analyze the gene expression profile.

Introduction

Liver regeneration is mostly associated with the self-renewal capacity of hepatocytes. Nevertheless, chronic liver injuries occur with progenitor cell activation and expansion, which have been associated with their ability to differentiate into hepatocytes and cholangiocytes^1,2,3,4. This is especially relevant because, during chronic injuries, hepatocyte proliferation is not effective. Despite multiple genetic tracing studies targeting progenitor cells, their role in liver regeneration remains controversial^5,6,7,8. Moreover, the activation of progenitor cells has been linked to increased fibrotic response in the liver, which raises questions about their exact role during injuries^9,10.

The heterogeneous nature of the progenitor cell compartment has long been suggested by gene expression studies that isolated progenitor cells expressing a single surface marker using microdissection or cell sorting-based methods^1,11. Indeed, recently, a novel surface marker combination using gp38 (podoplanin) unequivocally linked previous single markers of progenitor cells to various subsets¹². Importantly, these subsets not only differed in their surface marker expression but also exhibited functional alterations during injuries¹².

Multiple animal models have been utilized to investigate progenitor cell activation and liver regeneration. It seems that the various injury types promote the activation of differing subsets of progenitor cells¹². This might explain the phenotypic divergence of the ductular reaction observed in humans⁴. Thus, the complex phenotypic and functional analyses of progenitor cells are pivotal to understand their role in injuries and the true significance of the ductular reaction in liver diseases.

Besides surface marker combinations, the crucial differences in cell isolation protocols further complicate the conclusions based on previous studies². A substantial amount of studies addressed the role of progenitor cells that greatly differ in their isolation protocol (e.g., liver dissociation (enzyme combination and duration of the process), density medium, and centrifugation speed)². An optimized isolation technique, providing better viability for rare cell populations and reflective of subset composition, has been developed and published recently¹². The aim of this article is to provide a more detailed protocol of this liver cell isolation procedure and the subset analysis to allow for the proper reproduction of the technique. Additionally, the protocol includes a comparison with the previous isolation method to demonstrate the differences compared to the new protocol.

Protocol

All experimental procedures were conducted with the approval of the ethics and animal care committees of Homburg University Medical Center.

1. Preparation of Materials and Buffers

1. Freshly prepare all buffers required for liver digestion using sterile components and a laminar hood to avoid bacterial contamination.
2. Prepare the collection buffer (CB) by mixing 49.5 mL of RPMI medium and 0.5 mL of fetal bovine serum (FBS; low endotoxin, heat inactivated) to achieve a 1% (v/v) solution. Store the solution on ice until further usage.
   NOTE: Approximately 25 mL of CB is necessary to digest one whole liver.
3. Prepare the digestion buffer (DB) by using the following ingredients: RPMI medium, 1% (v/v) FBS (low endotoxin, heat inactivated), collagenase P (0.2 mg/mL), DNase-I (0.1 mg/mL), and dispase (0.8 mg/mL).
   NOTE: Approximately 25 mL of DB is necessary to digest one whole liver. Pre-warm the DB in the 37 °C water bath before use.
4. Reconstitute the enzymes upon arrival in Hanks' balanced salt solution (HBSS; collagense P and dispase) or in DNase-I buffer (50% (v/v) glycerol, 1 mM MgCl₂, and 20 mM Tris-HCl; pH 7.5), aliquot it, and store it at -20 °C. Store the DNase-I buffer at 4 °C and use it within two months.

2. Preparation of Liver Single-cell Suspension

1. Euthanize untreated wild-type mice by cervical dislocation in accordance with the local ethics and animal care committees.
2. Place the mice on a dissection board and wet the fur with 70% ethanol. Using scissors, open the abdomen with a midline incision of the skin, followed by a Y-incision towards the limbs. Open the peritoneum up to the sternum using the scissors. In order to uncover the liver, displace the intestine gently to the right side using a cotton swab.
3. With the help of scissors and forceps, remove the liver lobes, leaving the gall bladder behind, and avoid contamination with connective tissue. Weigh the liver and place it on ice in a Petri dish containing HBSS.
4. Place the liver lobes on a dry Petri dish and cut the liver tissue into homogeneous cubes approximately 2 mm a side by using a scalpel. Transfer the pieces into a 15-mL conical centrifuge tube.
5. Add 2.5 mL of DB to the 15-mL conical centrifuge tube containing the liver pieces and place it in a 37 °C water bath to start the digestion process (a healthy liver takes 60-70 min and a cirrhotic liver takes 80-90 min).
   NOTE: If one entire liver is being digested, the liver should be separated into two 15-mL conical centrifuge tubes to ensure good cell viability.
6. Prepare a new 15-mL conical centrifuge tube to collect released liver cells. Place a polyamide 100-µm filter mesh on the top of the tube and wet the mesh with 800 µL of CB. Place the conical centrifuge tube on ice.
7. Mix the samples in the 37 °C water bath after 5 and 10 min in order to support the digestion process by shaking the 15-mL conical centrifuge tube containing the liver pieces.
8. 15 min after starting the digestion, gently mix the liver pieces using a 1,000-µL pipette with a cut tip that enables the liver pieces to pass through easily. Place the tubes back into the water bath and allow the pieces to settle for 2 min.
9. Remove the supernatant containing the disseminated cells (typically 2x 700 µL) and add it to the tube prepared in step 2.6. Replace the removed supernatant with DB (2x 700 µL) and place it back into the 37 °C water bath.
10. Repeat the procedure described in step 2.8 (typically at 30, 40, 50, 55, and 60 min) until approximately 60-70 min have passed since the start of the digestion. From 40 min onwards, the remaining liver pieces should be small enough to pass through an uncut 1,000-µL pipette tip.
    NOTE: Healthy liver is digested fully within 60-70 min, while fibrotic liver typically needs 80-90 min. By this time point, the liver tissue should not be visible in the conical 15-mL centrifuge tube containing the liver pieces, and all released cells should be transferred into the tube prepared in step 2.6.
11. At the end of the digestion process, collect the cells and centrifuge them for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
12. Resuspend the cell pellet in 1 mL of ammonium-chloride-potassium (ACK) lysis buffer and incubate it for 1 min at room temperature in order to lyse the red blood cells. Stop the reaction by adding 5 mL of CB, and then centrifuge the cells for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2). Resuspend the cells in 4 mL of CB and store them on ice. Count the cells, as described in step 3.
    NOTE: The cell pellet is loose, and therefore the supernatant is pipetted away instead of being decanted.

3. Determination of the Cell Count Using Flow Cytometry

NOTE: For determining the cell counts, an automated cell counter or, ideally, the flow cytometry-based cell quantification described below is suggested instead of the classical Neubauer chamber-based method. The liver single-cell suspension described in step 2 contains parenchymal and non-parenchymal cells (NPC) with greatly differing sizes and granularities. The proper exclusion of cellular debris together with the gating-on forward scatter, side scatter (FSC-SSC) characteristic of NPCs when using flow cytometry ensures the success of the described protocol¹².

1. Prepare an aliquot of the liver cell suspension (20 µL) and add 174 µL of phosphate-buffered saline (PBS) and 6 µL of propidium iodine (PI; end concentration 0.375 µg/mL). Add counting beads that allow for the quantification of the cells.
2. Gate on SSC-A-FSC-A to avoid debris and further exclude doublets using FSC-H and FCS-A.
   NOTE: It is important to follow the gating strategy depicted in Figure 2.
3. Gate out PI-positive dead cells, measure 30 µL from your samples, and record the events. Follow the manufacturer's guideline to calculate the cell count.
   NOTE: Follow steps 4 for flow cytometry measurement, steps 5 and 6 for magnetic based progenitor cell isolation, and steps 7 for flow cytometry sort of progenitor subpopulations.

4. Staining of the Liver Single-cell Suspension for the Fow Cytometry Analysis of Progenitor Subsets

Antibody	Clone	Host/Isotype	Stock Concentration [mg/mL]	Dilution
CD64	X54-5/7.1	Mouse IgG1, κ	0.5	1:100
CD16/32	93	Rat IgG2a, λ	0.5	1:100
CD45	30-F11	Rat IgG2b, κ	0.2	1:200
CD31	MEC13.3	Rat IgG2a, κ	0.5	1:200
ASGPR1		Polyclonal Goat IgG	0.2	1:100
Podoplanin	1/8/2001	Syrian Hamster IgG	0.2	1:1,400
Podoplanin	1/8/2001	Syrian Hamster IgG	0.5	1:1,400
CD133	Mb9-3G8	Rat IgG1	0.03	3 µL
CD133	315-2C11	Rat IgG2a, λ	0.5	1:100
CD34	RAM34	Rat IgG2a, κ	0.5	1:100
CD90.2	53-2,1	Rat IgG2, κ	0.5	1:800
CD157	BP-3	Mouse IgG2b, κ	0.2	1:600
EpCAM	G8.8	Rat IgG2a, κ	0.2	1:100
Sca-1	D7	Rat IgG2a, κ	0.03	10 µL
Mouse IgG2b, κ	MPC-11		0.2
Rat IgG1	RTK2071		0.2
Rat IgG2b, κ	RTK4530		0.2
Rat IgG2a, κ	RTK2758		0.5
Rat IgG2a, κ	RTK2758		0.2
Syrian Hamster IgG	SHG-1		0.2
Syrian Hamster IgG	SHG-1		0.5
Normal Goat IgG Control		Polyclonal Goat IgG	1
Donkey anti-Goat IgG		Donkey IgG	2	1:800
Streptavidin			1	1:400

Table 1.

Antibody	1	2	3	4	5
CD45 APC/Cy7	Rat IgG2b, κ 0.5 µL	+	+	+	+
CD31 Biotin	+	Rat IgG2a, κ 0.5 µL	+	+	+
ASGPR1 purified	+	+	Normal Goat IgG Control 0.2 µL	+	+
Podoplanin APC	+	+	+	Syrian Hamster IgG 1 µL of a 1:14 Dilution	+
CD133 PE	+	+	+	+	Rat IgG1 0.45 µL
Donkey anti-Goat Alexa Fluor 488	+	+	+	+	+
Streptavidin Alexa Fluor 405	+	+	+	+	+

Table 2.

1. Place an aliquot of the cell suspension from step 2.11 into a reaction tube (1.5 mL) containing 2.5 x 10⁵ cells, determined as described in step 3.
2. Centrifuge the cells for 3 min at 300 x g and 4 °C using a microcentrifuge.
   NOTE: At this point, a vacuum pump can be utilized to carefully remove the supernatant.
3. Resuspend the cell pellet in Fc-block mix and incubate it for 5 min on ice. Prepare Fc-block mix with a total volume of 50 µL per stain. Add 10 µL of FcR-blocking reagent, 1 µL of purified anti-CD64 (1:100; 0.5 µg/stain), and 40 µL of staining buffer (ST buffer: HBSS, 1% (v/v) FBS, and 0.01% sodium azide) per stain.
   NOTE: Sodium azide is highly toxic. Use appropriate personal protective equipment, such as nitrile gloves, a laboratory coat, and a face mask.
4. Add 50 µL of staining mix to the cells (the total volume of cells is now 100 µL) and incubate the cells with the antibody mix, protected from light and for 20 min on ice.
5. Prepare the antibody mix with a total volume of 50 µL per stain. For 50 µL of ST buffer, add the following conjugated antibodies for basic staining: CD45 (0.5 µL; 1:200; 0.1 µg/stain), CD31 (0.5 µL; 1:200; 0.25 µg/stain), ASGPR1 (1 µL; 1:100; 0.2 µg/stain), podoplanin (1 µL of a 1:14 dilution; 1:1,400 end dilution; 0.014 µg/stain), and CD133 (3 µL; 0.09 µg/stain).
   NOTE: Table 1 summarizes the antibody clones and dilutions utilized for basic stains and for additional surface markers of the various subsets. Prepare extra cell suspensions for the antibody mix containing the corresponding isotype controls and/or fluorescence minus one controls (FMOs), as depicted in Table 2.
6. Add 400 µL of ST buffer to each sample and centrifuge the cells for 4 min at 300 x g and 4 °C.Discard the supernatant and resuspend the cells in 100 µL of secondary antibody mix containing 0.125 µL of donkey anti-goat IgG (1:800; 0.25 µg/stain) and 0.25 µL of fluorescent-conjugated streptavidin (1:400; 0.25 µg/stain) in 100 µL of ST buffer.
7. Incubate the cells while protected from light and with the antibody mix for 20 min on ice. Add 400 µL of ST buffer to each sample and centrifuge the cells for 4 min at 300 x g and 4 °C. Discard the supernatant and resuspend the cells in 300 µL of ST buffer containing 0.25 µg/mL PI.
   NOTE: The cell viability of progenitor cells decreases with the time; therefore, it is suggested to measure fresh samples as soon as possible.

5. Magnetic Microbead-based Enrichment of Progenitor Cells

1. Transfer an aliquot of the liver single-cell suspension containing 1.5-2 x 10⁶ cells, based on the cell count determined as described in step 3, into a new 15-mL conical centrifuge tube.
2. Centrifuge the cells for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
   NOTE: Typically, one healthy C57Bl/6 mouse liver (or 1 g of liver tissue) will need to be separated into three 15-mL conical centrifuge tube.
3. Resuspend the cells in 400 µL of HBSS 0.5% (v/v) bovine serum albumin (BSA) and add 40 µL of anti-CD31 microbeads and 30 µL of anti-CD45 microbeads. Incubate the cells for 15 min at 4 °C.
   NOTE: Do not exceed the incubation time, as the purity of the separation will be significantly reduced.
4. Add 5 mL of HBSS 0.5% (v/v) BSA to the cells and centrifuge them for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
5. Resuspend the cell pellet in 100 µL of dead cell removal beads and incubate them at room temperature for 15 min. In the meantime, prepare an LS separation column and calibrate it with 3 mL of HBSS 0.5% (v/v) BSA.
   NOTE: Do not exceed the incubation time, as the purity of the separation will be significantly reduced.
6. Add 900 µL of HBSS 0.5% (v/v) BSA to the cells, filter them using 100-µm polyamide filter mesh, and load them on the LS separation column.
   NOTE: Load one entire liver onto one LS separation column.
7. Wash the column three times with 3 mL of HBSS 0.5% (v/v) BSA and collect the flow-through.
8. Centrifuge the flow-through for 8 min at 180 x g and 4°C (using reduced acceleration/4 and deceleration/2).
9. Resuspend the cell pellet either in rinsing buffer (RB) (PBS and 2 mM ethylenediaminetetraacetic acid (EDTA)) containing 0.5% (v/v) BSA or ST buffer, depending upon the further experimental procedure.

6. Magnetic Microbead-based Automated Cell Purification of Progenitor Cell Subsets Combined from Multiple Livers

NOTE: Since progenitor cell subsets represent rare cell populations, combining cells from multiple livers is often needed to achieve sufficient cell numbers for further experiments. As an example, CD133⁺ and gp38⁺ cell separation is described below.

1. Isolation of CD133⁺ progenitors
   1. After step 5.9, count the cells, as described in step 3, and resuspend up to 10⁶ cells (typically pooling 4-6 healthy liver samples) in 100 µL of RB.
   2. Add anti-CD64 1:100 and anti-CD16/32 1:100 to the cells and incubate them on ice for 5 min. Add 1:100 anti-CD133 biotinylated antibody to the cells and incubate them on ice for a further 10 min.
   3. Add 5 mL of RB and centrifuge for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
   4. Resuspend the cells in 400 µL of RB and add 10 µL of anti-biotin microbeads. Incubate the sample for 15 min at 4 °C. Do not exceed the incubation time, as this reduces the purity of the samples.
   5. Add 5 mL of RB and centrifuge for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2). Resuspend the pellet in 1 mL of RB.
2. Isolation of gp38⁺ progenitors
   1. After step 5.9, count the cells, as described in step 3, and resuspend up to 10⁶ cells (typically pooling 4-6 healthy liver samples) in 100 µL of RB.
   2. Add anti-CD64 1:100 and anti-CD16/32 1:100 to the cells and incubate them on ice for 5 min. Next, add 1:100 anti-gp38 biotinylated antibody to the cells and incubate them on ice for a further 10 min.
   3. Add 5 mL of RB and centrifuge for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
   4. Resuspend the cells in 400 µL of RB and add 5 µL of anti-biotin microbeads. Incubate the sample for 15 min at 4 °C. Do not exceed the incubation time, as this reduces the purity of the samples.
   5. Add 5 mL of RB and centrifuge for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
   6. Resuspend the cell pellet in 1 mL of RB.
3. Common steps after step 6.1 or 6.2
   1. Place the 15-mL conical centrifuge tube containing the magnetically labeled cell suspensions on a chill 5 rack with two additional empty tubes for collecting the positive and negative fractions. Place the chill rack on the separation platform of the separator.
   2. Use the positive selection program (Possel_d2) with an extensive washing step between each sample (rinse option).
      NOTE: Using column-based manual separation of cells instead of the automatic separator will reduce the purity of the sample.
   3. Collect the positive fraction and centrifuge for 8 min at 180 x g and 4 °C (using reduced acceleration/4 and deceleration/2).
   4. Resuspend the cell pellet either in RB or ST buffer, depending upon the further experimental procedure.
   5. For a purity check, take an aliquot of the cells and stain them as described in step 4.

7. Flow Cytometry Cell Sorting

NOTE: A high purity sort of any progenitor cell subset could be achieved with the protocol described below. The overall yield of cells is much lower than that described in step 6 and is best for gene expression analysis.

Parameter	Setting
Nozzle Size	85 µm
Frequency	46.00 - 46.20
Amplitude	38.30 - 55.20
Phase	0
Drop Delay	28.68 - 28.84
Attenuation	Off
First Drop	284 - 297
Target Gap	9.-14
Pressure	45 psi

Table 3.

1. Acquire cells from the magnetic-based enrichment (described in step 5); count them, as described in step 3; and stain them for progenitor markers (CD133, gp38), CD31, ASGPR1 and CD45, as explained in step 4.
2. Prepare sorting medium (SM): phenol-red free Dulbecco's Modified Eagle's Medium (DMEM) containing 0.5% (v/v) BSA and 0.01% (v/v) sodium azide. Resuspend the stained cells in SM, transfer them into a polypropylene round-bottom tube, and place them on ice.
   NOTE: Sodium azide is highly toxic. Use appropriate personal protective equipment, such as nitrile gloves, a laboratory coat, and a face mask. Do not use sodium azide if the sorted cells are used for functional assays.
3. Use the appropriate software for the type of sorter used for the cell isolation. Open the software and follow the manufacturer's instructions to set up the sorting parameters and machine specifications.
   NOTE: The machine specifications are summarized in Table 3. While machine specifications could be different at various institutions, it is important to note that the reduction of sorting pressure and a larger nozzle size is necessary (45 psi and 85-µm nozzle) to increase the viability of the progenitor cell population and the quality of the RNA prepared from the sorted cells. It is important to use enriched liver progenitor cells for setting the compensation. Other liver or leukocyte populations have different auto-fluorescence and result in a suboptimal resolution of the stromal population and in a false gating strategy.
4. Calibrate the machine and place a 5-mL polypropylene round-bottom tube containing 350 µL of SM in the sort collection device. Start sample acquisition and sort. Collect 1,000 events of the subpopulation and stop the sample flow.
5. Take the tube out of the sorting device and measure the sorted cells on the flow cytometer. Identify the percentage of the sorted cell population present among the living cells. This percentage gives the purity of the sorted cells.
6. If sort purity exceeds 95%, place a 5-mL polypropylene round-bottom tube containing 350 µL of RLT lysis buffer in the sort collection device.
7. Start the sort and collect 7,000-10,000 events per stromal subpopulation.
8. Transfer the RLT lysis buffer containing the sorted cells in a DNase- and RNase-free reaction tube and store the samples at -80 °C until further analysis.

Results

The procedure presented here for the digestion of the liver using a novel mixture of enzymes results in a single-cell suspension containing parenchymal and non-parenchymal liver cells (Figures 1 and 2a). After the ACK-lysing of red blood cells, the direct flow cytometry analysis of the single-cell suspension is possible (Figures 1 and 2). The gating strategy involves the exclusion of doublets and dead cells (Figur...

Discussion

Liver inflammation and injury of different origins trigger regenerative processes in the liver that are accompanied by progenitor cell expansion and activation^2,3. These liver progenitor cells possess stem cell characteristics and likely play a significant role in the pathomechanism of various liver diseases.

The heterogeneity of liver progenitor cells has long been suggested. The re-evaluation of liver progenitor subsets using a novel...

Materials

Name	Company	Catalog Number	Comments
RPMI	Life Technologies	21875-034
phenol red free DMEM	Life Technologies	31053-028
FBS	Life Technologies	10270-106
Collagenase P	Sigma-Aldrich	11249002001
DNAse-I	Sigma-Aldrich	10104159001
Dispase	Life Technologies	17105041
ACK Lysing Buffer	Life Technologies	A10492-01
HBSS	Life Technologies	14025-050
PBS	Sigma-Aldrich	D8537
Sodium Azide	Sigma-Aldrich	S2002	Prepare 1% stock solution
10% BSA	Miltenyi Biotec	130-091-376
autoMACS Rinsing Solution	Miltenyi Biotec	130-091-222	add 0.5% (v/v) BSA and store on ice
Phenol-red free DMEM	Sigma-Aldrich	D1145
counting Beads Count Bright	Life Technologies	C36950
PI	Miltenyi Biotec	130-093-233
FcR Blocking Reagent	Miltenyi Biotec	130-092-575
anti-CD31 MicroBeads	Miltenyi Biotec	130-097-418
anti-CD45 MicroBeads	Miltenyi Biotec	130-052-301
Dead Cell Removal Kit	Miltenyi Biotec	130-090-101
anti-Biotin MicroBeads	Miltenyi Biotec	130-090-485
CD64 Purified	BioLegend	139302	Dilution: 1:100
CD16/32 Purified	BioLegend	101302	Dilution: 1:100
CD45 APC/Cy7	BioLegend	103116	Dilution: 1:200, marks hematopoetic cells
CD31 Biotin	BioLegend	102504	Dilution: 1:200, marks endothelial cells
ASGPR1 Purified	Bio-Techne	AF2755-SP	Dilution: 1:100, marks hepatocytes
Podoplanin APC	BioLegend	127410	Dilution: 1:1,400, marks progenior cells
Podoplanin Biotin	BioLegend	127404	Dilution: 1:1,400
CD133 PE	Miltenyi Biotec	130-102-210	use 3 µL, marks progenitor cells
CD133 Biotin	BioLegend	141206	Dilution: 1:100
CD34 Biotin	eBioScience	13-0341-81	Dilution: 1:100
CD90.2 Pacific Blue	BioLegend	140306	Dilution: 1:800
CD157 PE	BioLegend	140203	Dilution: 1:600
EpCAM Brilliant Violet 421	BioLegend	118225	Dilution: 1:100
Sca-1 Biotin	Miltenyi Biotec	130-101-885	use 10 µL
Mouse IgG2b, κ PE	BioLegend	400311
Rat IgG1 PE	BioLegend	400407
Rat IgG2b, κ APC/Cy7	BioLegend	400624
Rat IgG2a, κ Biotin	BioLegend	400504
Rat IgG2a, κ Brilliant Violet 421	BioLegend	400535
Syrian Hamster IgG APC	BioLegend	402012
Syrian Hamster IgG Biotin	BioLegend	402004
Normal Goat IgG Control Purified	Bio-Techne	AB-108-C
Donkey anti-Goat IgG Alexa Fluor 488	Life Technologies	A11055	Dilution: 1:800
Streptavidin Alexa Fluor 405	Life Technologies	S32351	Dilution: 1:400
100 µm Filter mesh	A. Hartenstein	PAS3
LS Column	Miltenyi Biotec	130-042-401
QuadroMACS separator	Miltenyi Biotec	130-090-976
MACSQuant Analyzer 10	Miltenyi Biotec	130-096-343
AutoMACS Pro Separator	Miltenyi Biotec	130-092-545
FACS AriaTMIII	BD Biosciences
FACSDiva sofware	BD Biosciences
Polypropylene Round bottom tube	Falcon	352063
Rneasy plus mini kit	Qiagen	74134	RLT lysis buffer is included